Cell calcium · 2026
Drug repurposing DMSO from an old solvent to a new candidate for the treatment of colitis and sepsis in male mice.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pang Shude, Rong Shaoya, Zhang Yanan, Tong Shuo, Gong Yanhua, Zhao Wenwen, Dong Hui
Аннотация
Normal microvascular function is critical for tissue perfusion, and intestinal vascular dysfunction is a major pathological feature of colitis and sepsis. Although dimethyl sulfoxide (DMSO) as a versatile solvent exerts anti-inflammatory and vasoactive properties in conduit vessels, its pharmacological effects on arterioles have not been explored. This study repurposed it as a potential therapeutic agent for these two gut-derived inflammatory diseases, aiming to elucidate its direct effects and underlying mechanisms on intestinal resistance arterioles under both physiological and pathological conditions. Mulvany-style wire myography was used to assess DMSO-induced vasorelaxation in murine mesenteric arterioles. Intracellular Ca2+ dynamics in human umbilical vein endothelial cells (HUVECs) were assessed using Ca2+ imaging, and the membrane potential changes were monitored by patch clamp. Mouse models of dextran sulfate sodium (DSS)-induced colitis and cecal ligation puncture (CLP)-induced sepsis were used. To this end, we showed that DMSO elicited concentration-dependent vasorelaxation of mesenteric arterioles, predominantly mediated by endothelium-dependent hyperpolarization (EDH) mechanism in healthy mice. DMSO activated PLC/IP3/IP3R signaling pathway and store-operated Ca2+ entry (SOCE) in endothelial cells to trigger EDH-mediated vasorelaxation. In colitic and septic mice, DMSO significantly alleviated the severity of the diseases, such as body weight, stool score, colon length, and survival rate. Moreover, DMSO/EDH-mediated vasorelaxation was largely preserved in colitic and septic mice. Importantly, DMSO pretreatment restored the ACh/EDH-mediated vasorelaxation impaired in colitic and septic mice. This study reveals a previously overlooked pharmacological effect of DMSO as a common solvent, strongly suggesting that it could be repositioned as a safe therapeutic agent for improving microcirculation under inflammatory conditions, such as colitis and sepsis.